Bladder cancer study halted early: hormone therapy plus chemo tested in just 2 patients
Disease control
Terminated
This study tested whether adding a drug called degarelix, which lowers testosterone, to standard chemotherapy could help treat muscle-invasive bladder cancer. Only people whose tumors had testosterone receptors were included. The study was stopped early after enrolling just 2 par…
Phase: PHASE1 • Sponsor: Brown University • Aim: Disease control
Last updated May 13, 2026 16:01 UTC